Bigger jump will ensue when trial announced unless the result is moderated by reactions from other drug companies and drug administrations to a primary liver cancer treatment. Legal and governance considerations will still be present ALL IMHO but pls DYOR. A $6 billion market cap needs a positive run of results starting with the clinical trial result and the legal response globally to a primary liver cancer treatment.
Dramatic response to SIRT, page-25
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
15.5¢ |
Change
-0.005(3.13%) |
Mkt cap ! $65.79M | |||
| Open | High | Low | Value | Volume |
| 16.0¢ | 16.0¢ | 15.3¢ | $395.4K | 2.535M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 2728183 | 15.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.5¢ | 84474 | 2 |
View Market Depth
| Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
| SRX (ASX) Chart |